These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9634724)

  • 21. [The therapy of complicated forms of essential hypertension with the ACE inhibitor perindopril].
    Inzhutova AI; Petrova MM; Salmina AB
    Klin Med (Mosk); 2007; 85(11):58-61. PubMed ID: 18219959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
    Pretorius M; McFarlane JA; Vaughan DE; Brown NJ; Murphey LJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):379-87. PubMed ID: 15470338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
    Marre M; Leye A
    Diab Vasc Dis Res; 2007 Sep; 4(3):163-73. PubMed ID: 17907106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus].
    Zonis BIa; Volkova NI; Sokolov OIu
    Ter Arkh; 2000; 72(2):53-5. PubMed ID: 10717928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Postulosis palmoplantaris caused by angiotensin-converting enzyme inhibitors].
    Eriksen JG; Christiansen JJ; Asmussen I
    Ugeskr Laeger; 1995 Jun; 157(23):3335-6. PubMed ID: 7631443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity.
    Damas J; Garbacki N; Lefèbvre PJ
    Diabetes Metab Res Rev; 2004; 20(4):288-97. PubMed ID: 15250031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
    Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
    J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Circ J; 2002 Sep; 66(9):811-5. PubMed ID: 12224817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ACE-inhibitors and glucose metabolism].
    Dietze GJ; Rett K; Wicklmayr M; Mehnert H
    Wien Med Wochenschr; 1990 Jan; 140(1-2):35-9. PubMed ID: 2408249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme in diabetes mellitus dependence on metabolic aberration.
    Schmitz O; Rømer FK; Alberti KG; Hreidarsson AB; Orskov H
    Diabete Metab; 1983 Sep; 9(3):179-82. PubMed ID: 6317477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin resistance, hypertension and diabetes--value of Metformin and ACE-inhibitors].
    Internist (Berl); 1994 Jun; 35(6 Suppl):1-8. PubMed ID: 9131073
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood serum angiotensin-converting enzyme, alfa2-macroglobulin and triglycerides in patients with diabetes.
    Skowron-Szlósarczyk S; Podwysocki B; Wysocka E; Paczyński A
    Mater Med Pol; 1992; 24(4):268-70. PubMed ID: 1284970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
    Jandrain B; Herbaut C; Depoorter JC; Voorde KV
    Am J Med; 1992 Apr; 92(4B):91S-94S. PubMed ID: 1580288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans.
    Uehara M; Kishikawa H; Isami S; Kisanuki K; Ohkubo Y; Miyamura N; Miyata T; Yano T; Shichiri M
    Diabetologia; 1994 Mar; 37(3):300-7. PubMed ID: 8174845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjects.
    Reid JL; Lees KR; Perret L
    Clin Exp Hypertens A; 1987; 9(2-3):361-4. PubMed ID: 3038395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme determination in plasma during therapy with converting enzyme inhibitor: two methods compared.
    Gorski TP; Campbell DJ
    Clin Chem; 1991 Aug; 37(8):1390-3. PubMed ID: 1651180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure.
    Donnelly R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S38-44. PubMed ID: 1284142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of blood glucose levels to the changes in plasma levels of various hydrolytic enzymes in diabetic patients.
    Aoyagi T; Wada T; Kojima F; Nagai M; Akanuma Y; Akanuma H; Umezawa H
    Biochem Int; 1985 May; 10(5):821-7. PubMed ID: 2990478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.